Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing

被引：0

作者：

机构：

[1] [1,Rouet, Romain

[2] Thuma, Benjamin A.

[3] Roy, Marc D.

[4] Lintner, Nathanael G.

[5] Rubitski, David M.

[6] Finley, James E.

[7] Wisniewska, Hanna M.

[8] 2,Mendonsa, Rima

[9] 2,Hirsh, Ariana

[10] 2,De Oñate, Lorena

[11] 2,Compte Barrón, Joan

[12] McLellan, Thomas J.

[13] Bellenger, Justin

[14] Feng, Xidong

[15] Varghese, Alison

[16] Chrunyk, Boris A.

[17] Borzilleri, Kris

[18] Hesp, Kevin D.

[19] 1,Zhou, Kaihong

[20] 1,Ma, Nannan

[21] Tu, Meihua

[22] Dullea, Robert

[23] McClure, Kim F.

[24] 2,Wilson, Ross C.

[25] Liras, Spiros

[26] Mascitti, Vincent

[27] 1,2,3,4,5,Doudna, Jennifer A.

来源：

Liras, Spiros (spiros.liras@pfizer.com) | 2018年 / American Chemical Society卷 / 140期

关键词：

Number:; 86059; Acronym:; -; Sponsor:; APP1090875; Sponsor: National Health and Medical Research Council;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
Rouet, Romain
Thuma, Benjamin A.
Roy, Marc D.
Lintner, Nathanael G.
Rubitski, David M.
Finley, James E.
Wisniewska, Hanna M.
Mendonsa, Rima
Hirsh, Ariana
de Onate, Lorena
Barron, Joan Compte
McLellan, Thomas J.
Bellenger, Justin
Feng, Xidong
Varghese, Alison
Chrunyk, Boris A.
Borzilleri, Kris
Hesp, Kevin D.
Zhou, Kaihong
Ma, Nannan
Tu, Meihua
Dullea, Robert
McClure, Kim F.
Wilson, Ross C.
Liras, Spiros
Mascitti, Vincent
Doudna, Jennifer A.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (21) : 6596 - 6603
[2] Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell Type Specific Gene Editing
Roy, Marc
Rouet, Romain
Thuma, Benjamin
Lintner, Nathanael
Rubitski, David
Finley, James
Wisniewska, Hanna
Mendonsa, Rima
de Onate, Lorena
Hirsh, Ariana
Barron, Joan Compte
McLellan, Thomas
Bellenger, Justin
Feng, Xidong
Varghese, Alison
Chrunyk, Boris
Borzilleri, Kris
Hesp, Kevin
FASEB JOURNAL, 2018, 32 (01):
[3] Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch
Hirosawa, Moe
Fujita, Yoshihiko
Parr, Callum J. C.
Hayashi, Karin
Kashida, Shunnichi
Hotta, Akitsu
Woltjen, Knut
Saito, Hirohide
NUCLEIC ACIDS RESEARCH, 2017, 45 (13)
[4] Delivery of an endosomolytic CRISPR-Cas9 RNP via receptor-mediated endocytosis for cell-targeted genome editing
de Onate, L.
Foss, D.
Mendonsa, R.
Wilson, R.
HUMAN GENE THERAPY, 2019, 30 (11) : A198 - A198
[5] Identification of a novel ASGPr ligand and application to receptor mediated delivery and celltype specific gene editing with CRISPR-Cas9 ribonucleoproteins
Thuma, Benjamin
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[6] CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
Blenke, Erik Oude
Evers, Martijn J. W.
Mastrobattista, Enrico
van der Oost, John
JOURNAL OF CONTROLLED RELEASE, 2016, 244 : 139 - 148
[7] Controlling CRISPR-Cas9 Gene Editing
Dowdy, Steven F.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
[8] Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing
Balaraman, Ashok Kumar
Babu, M. Arockia
Moglad, Ehssan
Mandaliya, Viralkumar
Rekha, M. M.
Gupta, Sofia
Prasad, G. V. Siva
Kumari, Mukesh
Chauhan, Ashish Singh
Ali, Haider
Goyal, Kavita
PATHOLOGY RESEARCH AND PRACTICE, 2025, 266
[9] Introduction to CRISPR-Cas9 Gene Editing
Mason, J. M.
BIRTH DEFECTS RESEARCH, 2020, 112 (11): : 809 - 809
[10] Delivery of an Endosomolytic CRISPR-Cas9 RNP Enzyme via Receptor-Mediated Endocytosis for Targeted Genome Editing of T Cells
Wilson, Ross
de Onate, Lorena
Foss, Dana
Mendonsa, Rima
MOLECULAR THERAPY, 2020, 28 (04) : 472 - 472

← 1 2 3 4 5 →